Biotech giant Amgen is eliminating 50 jobs from its Seattle-area operations as it seeks to cut costs amid the fizzling of its pivotal anemia drug business.The jobs eliminated represented “a variety of functions,” Amgen spokeswoman Carol Pawlak said Friday. The affected employees, who left the company this past week, will receive a minimum 24 weeks of severance pay, continued health-care coverage and career help, Pawlak said.
